Menu utilisateur

Accès à distance ? S'identifier sur le proxy UCLouvain

Rechercher

Affichage: 5 résultats.
    • Communication
    Allogeneic SCT planned in CR-1 after intensive chemotherapy in patients with bad prognosis MDS results in better outcome in the intermediate/high-risk cytogenetic group: a study by the EORTC, EBMT, SAKK, HOVON and GIMEMA Leukemia Groups
    de Witte, T. Hagemeijer, Anne Suciu, Stefan[UCL] Belhabri, A Delforge, Michel Aul, C Aivado, M Selleslag, D. Schouten, H Ferrant, Augustin[UCL] Biersack, H Amadori, S. Muus, P. Jehn, U. Beeldens, F. Jansen, J Hellstrom-Lindberg, P Ossenkoppele, G Gratwohl, A. Marie, JP Willemze, R. (2006) 32nd Annual Meeting of the European-Group-for-Blood-and-Morrow-Transplantation/22nd Meeting of the EBMT-Nures-Group/5th Meeting of the EMBT-Data-Management-Group — Hamburg (Germany)
    • Article de périodique
    The presence of an HLA-identical sibling donor has no impact on outcome of patients with high-risk MDS or secondary AML (sAML) treated with intensive chemotherapy followed by transplantation: results of a prospective study of the EORTC, EBMT, SAKK and GIMEMA Leukemia Groups (EORTC study 06921)
    Oosterveld, M Ferrant, Augustin[UCL] Suciu, Stefan[UCL] Verhoef, G. Labar, B. Belhabri, A Aul, C Selleslag, D. Wijermans, P Mandelli, F. Amadori, S. Jehn, U. Muus, P. Zittoun, R Hess, U. Anak, O Beeldens, F. Willemze, R. de Witte, T. (2003) Leukemia — Vol. 17, no. 5, p. 859-868 (2003)
    • Article de périodique
    Chemotherapy only compared to chemotherapy followed by transplantation in high risk myelodysplastic syndrome and secondary acute myeloid leukemia; two parallel studies adjusted for various prognostic factors
    Oosterveld, M Ferrant, Augustin[UCL] Muus, P. Suciu, Stefan[UCL] Koller, C Verhoef, G. Labar, B. Wijermans, P Aul, C Fiere, D. Selleslag, D. Willemze, R. Gratwohl, A. Mandelli, F. Cortes, J de Witte, T. Estey, E (2002) Leukemia — Vol. 16, no. 9, p. 1615-1621 (2002)
    • Communication
    Intensive chemotherapy versus autologous or allogeneic stemcell transplantation for the treatment of patients with poor risk MDS and secondary AML-A joint study of the Eortc, Ebmt, Hovon, Swiss, Scandinavian and Gimema leukemia groups: A biomed-2 EU-project.
    deWitte, TM Ferrant, Augustin[UCL] Suciu, Stefan[UCL] Anak, O Hagemeijer, Anne[UCL] Selleslag, D. Delforge, Michel[UCL] Belhabi, A Schouten, H Gratwohl, A. Aul, C Aivado, M Amadori, S. Muus, P. Tigaud, I. Jotterand-Bellomo, M Willemze, R. (1999) —
    • Article de périodique
    Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDS
    de Witte, T. Ferrant, Augustin[UCL] Suciu, Stefan[UCL] Verhoef, G. Labar, B. Archimbaud, E. Aul, C Selleslag, D. Wijermans, P Mandelli, F. Amadori, S. Jehn, U. Muus, P. Boogaerts, M. Zittoun, R Gratwohl, A. Zwierzina, H Hagemeijer, Anne[UCL] Willemze, R. (2001) Blood — Vol. 98, no. 8, p. 2326-2331 (2001)